- What are the top holdings of BIB?
- ProShares Ultra Nasdaq Biotechnology holds 274 securities in total. The largest positions and their portfolio weights are listed on the Holdings tab.
- How many holdings does BIB have?
- BIB holds 274 positions as reported by the fund's most recent disclosure.
- What sectors does BIB invest in?
- ProShares Ultra Nasdaq Biotechnology (BIB) allocates across the sectors shown above. The largest exposure tops the list; the rest follow in descending weight order.
- What sector is BIB most exposed to?
- BIB's full sector breakdown is on the Sectors tab. The largest sector weight is shown there along with the rest of the allocation.
- Is BIB a US-only fund?
- The country allocation card on this page shows BIB's geographic exposure. Funds with > 95% US weight are effectively US-only; international or global funds will show meaningful weights across multiple countries.
- What does BIB invest in?
- ProShares Trust - ProShares Ultra Nasdaq Biotechnology is an exchange traded fund launched and managed by ProShare Advisors LLC. It invests in public equity markets of the United States. It invests through derivatives in stocks of companies operating across health care, pharmaceuticals, biotechnology, drugs manufacturer, diagnostic development and life sciences sectors. It uses derivatives such as swaps to create its portfolio. The fund invests in growth and value stocks of companies across diversified market capitalization. The fund seeks to track 2x the daily performance of the Nasdaq Biotechnology Index, by using full replication technique. ProShares Trust - ProShares Ultra Nasdaq Biotechnology was formed on April 7, 2010 and is domiciled in the United States.
